S
Sverre E. Kjeldsen
Researcher at University of Oslo
Publications - 771
Citations - 95426
Sverre E. Kjeldsen is an academic researcher from University of Oslo. The author has contributed to research in topics: Blood pressure & Left ventricular hypertrophy. The author has an hindex of 94, co-authored 735 publications receiving 89059 citations. Previous affiliations of Sverre E. Kjeldsen include University of Michigan & Cornell University.
Papers
More filters
Journal ArticleDOI
Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes
Michael A. Weber,George L. Bakris,Kenneth Jamerson,Matthew R. Weir,Sverre E. Kjeldsen,Richard B. Devereux,Eric J. Velazquez,Björn Dahlöf,Roxzana Y. Kelly,Tsushung A. Hua,Allen Hester,Bertram Pitt,Accomplish Investigators +12 more
TL;DR: In patients with Diabetes and hypertension, combining a renin-angiotensin system blocker with amlodipine, compared with hydrochlorothiazide, was superior in reducing cardiovascular events and could influence future management of hypertension in patients with diabetes.
Journal ArticleDOI
2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension
Journal ArticleDOI
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration
Koon K. Teo,Peter Sleight,Peggy Gao,Salim Yusuf,Stuart J. Connolly,Karl Swedberg,Marc A. Pfeffer,Christopher B. Granger,John J.V. McMurray,Anne K. Sjoelie,Barry M. Massie,Peter E. Carson,Julia B. Lewis,Kristian Wachtell,Björn Dahlöf,Richard B. Devereux,Sverre E. Kjeldsen,Stevo Julius,Hans Ibsen,Lars H Lindholm,Michael H. Olsen,Peter M. Okin,Robert M. Califf,Rury R. Holman,Steven M. Haffner,Gilles R. Dagenais,Jeffrey L. Probstfield,Craig S. Anderson,Rafael Diaz,Antonio L. Dans,Mark Levine,Thomas Unger,Robert Fagard,Hans-Christoph Diener,Ralph L. Sacco,Alberto Zanchetti,Jay N. Cohn,Marc Weber +37 more
TL;DR: There was no significant increase in the overall or site-specific cancer risk from ARBs compared to controls, and there was no excess of lung, prostate or breast cancer, or overall cancer deaths associated with ARB treatment.
Journal ArticleDOI
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
Peter Willeit,Lena Tschiderer,Elias Allara,Kathrin Reuber,Lisa Seekircher,Lu Gao,Ximing Liao,Eva Lonn,Hertzel C. Gerstein,Salim Yusuf,Frank P. Brouwers,Folkert W. Asselbergs,Wiek H. van Gilst,Sigmund A. Anderssen,Diederick E. Grobbee,John J.P. Kastelein,Frank L.J. Visseren,George Ntaios,Apostolos I. Hatzitolios,Christos Savopoulos,Pythia T. Nieuwkerk,Erik S.G. Stroes,Matthew Walters,Peter Higgins,Jesse Dawson,Paolo Gresele,Giuseppe Guglielmini,Rino Migliacci,Marat V. Ezhov,Maya S. Safarova,T.V. Balakhonova,Eiichi Sato,Mayuko Amaha,Tsukasa Nakamura,Kostas Kapellas,Lisa Jamieson,Michael R. Skilton,James A. Blumenthal,Alan L. Hinderliter,Andrew Sherwood,Patrick Smith,Michiel A. Van Agtmael,Peter Reiss,Marit G.A. Van Vonderen,Stefan Kiechl,Gerhard Klingenschmid,Matthias Sitzer,Coen D.A. Stehouwer,Heiko Uthoff,Zhiyong Zou,Ana Rosa Cunha,Mario Fritsch Neves,Miles D. Witham,Hyun Woong Park,Moo Sik Lee,Jang Ho Bae,Enrique Bernal,K. Wachtell,Sverre E. Kjeldsen,Michael H. Olsen,David Preiss,Naveed Sattar,Edith Beishuizen,Menno V. Huisman,Mark A. Espeland,Caroline Schmidt,Stefan Agewall,Ercan Ok,Gulay Asci,Eric de Groot,Muriel P.C. Grooteman,Peter J. Blankestijn,Michiel L. Bots,Michael J. Sweeting,Simon G. Thompson,Matthias W. Lorenz +75 more
TL;DR: The extent of intervention effects on cIMT progression predicted the degree of CVD risk reduction, providing a missing link supporting the usefulness of cIMt progression as a surrogate marker for CVDrisk in clinical trials.
Journal ArticleDOI
Exercise Blood Pressure Predicts Mortality From Myocardial Infarction
TL;DR: Exercise blood pressure is a stronger predictor than casual blood pressure of morbidity and mortality from myocardial infarction, and an early rise in systolic blood pressure during exercise adds prognostic information about mortality among otherwise healthy middle-aged men with mildly elevatedcasual blood pressure.